Clearwater Analytics Announces First Quarter 2025 Financial Results

Business Wire
05-01

Record Quarterly Revenue of $126.9 Million, Up 24% Year-Over-Year

Annualized Recurring Revenue of $493.9 Million, Up 23% Year-Over-Year

Gross Revenue Retention Rate of 98%; Net Revenue Retention Rate of 114%

Net Income of $6.9 Million

Adjusted EBITDA of $45.1 Million, Up 40% Year-Over-Year

BOISE, Idaho, April 30, 2025--(BUSINESS WIRE)--Clearwater Analytics Holdings, Inc. (NYSE: CWAN) ("Clearwater Analytics" or the "Company"), the most comprehensive technology platform for investment management, today announced its financial results for the quarter ended March 31, 2025.

"In Clearwater's final quarter prior to its acquisitions of Enfusion, Beacon and Bistro, I'm incredibly proud to report both exceptional results and milestone achievements. Since our first Investor Day in 2023, our execution has consistently exceeded expectations across key metrics, such as gross margins reaching 78.9%, approaching our 80% target ahead of schedule, and R&D spend decreasing from 25-26% to 21.6% of revenue. While we initially projected margin improvements of 50 and 200 basis points in gross margin and EBITDA, respectively, we’ve delivered growth at a significantly faster pace. Our value proposition has proven even more compelling in volatile market environments because institutional investors need to see a comprehensive view of their global assets with greater frequency and sophistication," said Sandeep Sahai, CEO at Clearwater Analytics. "While our metrics will reset following the completion of our acquisitions, our long-term goals remain unchanged and our journey of improvement will continue unabated. Our strong ARR growth, expanding margins, and improved efficiencies demonstrate our progress as we continue to reshape the future of investment operations with the industry’s most comprehensive investment management platform."

"We’re very pleased with Clearwater’s first quarter results. In addition to our strong revenue and stellar EBITDA, our free cash flow generation in the quarter increased 168% year-over-year. I’m also pleased to report that Enfusion’s Q1 2025 preliminary revenue was $54.5 million, or 13% year-over-year growth, consistent with what we had expected," said Jim Cox, CFO at Clearwater Analytics.

First Quarter 2025 Financial Results Summary

  • Revenue: Total revenue for the first quarter of 2025 was $126.9 million, an increase of 23.5%, from $102.7 million in the first quarter of 2024.
  • Gross Profit: Gross profit for the first quarter of 2025 increased to $92.9 million, which equates to a 73.3% GAAP gross margin, compared with gross profit of $74.5 million and GAAP gross margin of 72.6% in the first quarter of 2024. Non-GAAP gross profit for the first quarter of 2025 was $100.1 million, which equates to a 78.9% non-GAAP gross margin and an increase of 80 basis points over the first quarter of 2024.
  • Net Income: Net income for the first quarter of 2025 was $6.9 million, compared with net income of $2.2 million in the first quarter of 2024. Non-GAAP net income for the first quarter of 2025 increased to $34.9 million, an increase of 33.1% from $26.2 million in the first quarter of 2024.
  • Adjusted EBITDA: Adjusted EBITDA for the first quarter of 2025 was $45.1 million, an increase of 40.0%, from $32.2 million in the first quarter of 2024. Adjusted EBITDA margin for the first quarter of 2025 was 35.5%, an increase of 420 basis points over the first quarter of 2024.
  • Cash Flows: Operating cash flows for the first quarter of 2025 were $24.5 million. Free cash flows for the first quarter of 2025 were $23.0 million, an increase of 167.8% over the first quarter of 2024.
  • Earnings Per Share and Non-GAAP Net Income Per Share attributable to Clearwater Analytics Holdings, Inc.: Earnings per basic share was $0.03, and earnings per diluted share was $0.03 in the first quarter of 2025. Non-GAAP net income per basic share was $0.15, and non-GAAP net income per diluted share was $0.13 in the first quarter of 2025.
  • Cash, cash equivalents, and investments were $282.9 million as of March 31, 2025. Total debt, net of debt issuance cost, was $45.2 million as of March 31, 2025.

First Quarter 2025 Key Metrics Summary

  • Annualized Recurring Revenue: As of March 31, 2025, annualized recurring revenue ("ARR") reached $493.9 million, an increase of 22.7% from $402.3 million as of March 31, 2024.

ARR is calculated at the end of a period by dividing the recurring revenue in the last month of such period by the number of days in the month and multiplying by 365.

  • Gross Revenue Retention Rate: As of March 31, 2025, the gross revenue retention rate was 98%, compared to 99% as of March 31, 2024.

Gross revenue retention rate represents annual contract value ("ACV") at the beginning of the 12-month period ended on the reporting date less client attrition over the prior 12-month period, divided by ACV at the beginning of the 12-month period, expressed as a percentage. ACV is comprised of annualized recurring revenue plus contracted-not-billed revenue, which represents the estimated annual contracted revenue for new and existing client opportunities prior to revenue recognition.

  • Net Revenue Retention Rate: As of March 31, 2025, the net revenue retention rate was 114%, compared to 116% as of December 31, 2024 and 110% as of March 31, 2024.

Net revenue retention rate is the percentage of recurring revenue from clients on the platform for 12 months and includes changes from the addition, removal, or value of assets on our platform, contractual changes that have an impact to annualized recurring revenues and lost revenue from client attrition.

Recent Business Highlights

  • Clearwater completed its acquisitions of Beacon today and Enfusion on April 21, 2025, and an asset purchase of Blackstone’s proprietary portfolio visualization software platform, Bistro, on March 31, 2025. These acquisitions aim to accelerate Clearwater’s vision of creating a unified, real-time portfolio view across all asset types—from public equities and private credit to structured products and alternatives—in a single, cloud-native platform, ultimately building the first comprehensive cloud-native front-to-back solution for the entire investment management industry.
  • The Company expanded its footprint within existing clients and added marquee clients such as: AllianceBernstein LP US, Allied Trust Insurance Company, Central Bank of Peru, Community Funds, Inc., Community Health Plan of WA, Crosslight Global Investment Partners, El Paso Community Foundation, Elan Insurance USVI, Inc., Grange Insurance Association, Kayne Anderson Rudnick Investment Management, Le Sphinx Assurances Luxembourg S.A., Marquette Indemnity & Life Insurance Company, McCormick & Company, Incorporated, Mirum Pharmaceuticals, Inc., Rho Capital Partners, Inc., Security Mutual, Southern Vanguard Insurance Co., SSA Marine, Suecia Insurance Company, Universal Insurance Holdings of North America, Inc., and Vault Insurance.
  • The Company announced that it won the Technology Provider of the Year Excellence Award for the third consecutive year. The InsuranceAsia News Excellence Awards, which celebrates the best firms in the Asia Pacific (re)insurance market, honored Clearwater for playing a crucial role in helping insurers achieve efficiency and analytical superiority and leveraging new technologies to future-proof their business and the industry.

Guidance for Clearwater Analytics (excluding Enfusion and Beacon acquisitions):

 

Second Quarter 2025

Revenue

$129 million

Year-over-Year Growth %

~21%

Adjusted EBITDA

$45 million

Adjusted EBITDA Margin %

~35%

*Combined guidance for pro-rated revenue of Enfusion and Beacon in the second quarter for a total impact of acquired revenue for the second quarter of 2025 of $45 million. The combined contribution of the acquired businesses pro-rated Adjusted EBITDA for the second quarter of 2025 is $8 million. This guidance assumes pro-rated amount of revenue and Adjusted EBITDA from the closing date of each acquisition to the end of the second quarter of 2025.

Consolidated Guidance for Clearwater Analytics (including Enfusion and Beacon acquisitions from the closing date of each acquisition):

 

Full Year 2025

Revenue

$720 million to $728 million

Year-over-Year Growth %

~59% to 61%

Adjusted EBITDA

$230 million to $235 million

Adjusted EBITDA Margin %

~32%

Total equity-based compensation expense and related payroll taxes (including one-time charges)

~$139 million

Depreciation and Amortization

~$100 million to $120 million

Non-GAAP effective tax rate

25%

Diluted non-GAAP share count

~$303 million

Certain components of the guidance given above are provided on a non-GAAP basis only without providing a reconciliation to guidance provided on a GAAP basis. Information is presented in this manner because the preparation of such a reconciliation could not be accomplished without "unreasonable efforts." The Company does not have access to certain information that would be necessary to provide such a reconciliation, including non-recurring items that are not indicative of the Company’s ongoing operations. The Company does not believe that this information is likely to be significant to an assessment of the Company’s ongoing operations.

Conference Call Details

Clearwater Analytics will hold a conference call and webcast on April 30, 2025, at 5:00 p.m. Eastern time to discuss first quarter 2025 financial results, provide a general business update, and respond to analyst questions.

A live webcast of the call will also be available on the Company’s investor relations website. Please visit investors.clearwateranalytics.com at least fifteen minutes prior to the start of the event to register, download and install any necessary audio software.

If you are unable to participate live, a replay of the webcast will be available following the conference call on the Company’s investor relations website, along with the earnings press release, and related financial tables.

About Clearwater Analytics

Clearwater Analytics (NYSE: CWAN) is transforming investment management with the industry’s most comprehensive cloud-native platform for institutional investors across global public and private markets. While legacy systems create risk, inefficiency, and data fragmentation, Clearwater’s single-instance, multi-tenant architecture delivers real-time data and AI-driven insights throughout the investment lifecycle. The platform eliminates information silos by integrating portfolio management, trading, investment accounting, reconciliation, regulatory reporting, performance, compliance, and risk analytics in one unified system. Serving leading insurers, asset managers, hedge funds, banks, corporations, and governments, Clearwater supports over $8.8 trillion in assets globally. Learn more at clearwateranalytics.com.

Use of non-GAAP Information

This press release contains certain non-GAAP measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow.

The non-GAAP measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similar measures presented by other companies. However, the Company believes that this non-GAAP information is useful as an additional means for investors to evaluate its operating performance, when reviewed in conjunction with its GAAP financial statements. These measures should not be considered in isolation or as a substitute for measures prepared in accordance with GAAP, and because these amounts are not determined in accordance with GAAP, they should not be used exclusively in evaluating the Company's business and operations. In addition, undue reliance should not be placed upon non-GAAP or operating information because this information is neither standardized across companies nor subjected to the same control activities and audit procedures that produce the Company's GAAP financial results.

The Company's non-GAAP statement of operations measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow, are adjusted to exclude the impact of certain costs, expenses, gains and losses and other specified items that management believes are not indicative of its ongoing operations. These adjusted measures exclude the impact of share-based compensation and eliminate potential differences in results of operations between periods caused by factors such as financing and capital structures, taxation positions or regimes, restructuring, transaction expenses, impairment and other charges. Please refer to the reconciliations of these measures below to what the Company believes are the most directly comparable measures evaluated in accordance with GAAP.

Use of Forward Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the timing of the consummation of acquisition of Enfusion and the ability to satisfy closing conditions, the Company's possible or assumed future results of operations, business strategies, technology developments, financing and investment plans, dividend policy, competitive position, industry, economic and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "aim," "may," "plan," "potential," "predict," "project," "seek," "should," "will," "would" or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control, that may cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties may cause actual results to differ materially from Clearwater Analytics’ current expectations and include, but are not limited to, the Company’s ability to successfully integrate the operations and technology of its recently completed acquisitions of Enfusion, Beacon and Bistro (the "Recent Acquisitions") with those of the Company and to obtain third party data rights, retain and incentivize the employees of the Recent Acquisitions following the close of the Recent Acquisitions, retain the Recent Acquisitions’ clients, repay debt to be incurred in connection with the Recent Acquisitions and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies and growth from the Recent Acquisitions may not be fully realized or may take longer to realize than expected, the Company's ability to keep pace with rapid technological change and market developments, including artificial intelligence, competitors in its industry, the possibility that market volatility, a downturn in economic conditions or other factors may cause negative trends or fluctuations in the value of the assets on the Company’s platform, the Company's ability to manage growth, the Company’s ability to attract and retain skilled employees, the possibility that the Company’s solutions fail to perform properly, disruptions and failures in the Company's and third parties’ computer equipment, cloud-based services, electronic delivery systems, networks and telecommunications systems and infrastructure, the failure to protect the Company, its customers’ and/or its vendors’ confidential information and/or intellectual property, claims of infringement of others’ intellectual property, factors related to the Company's ownership structure as well as other risks and uncertainties detailed in Clearwater Analytics’ periodic public filings with the U.S. Securities and Exchange Commission (the "SEC"), including but not limited to those discussed under "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed on February 26, 2025 (as amended by Amendment No. 1 thereto, filed with the SEC on March 7, 2025), and in other periodic reports filed by the Company with the SEC. These filings are available at www.sec.gov and on the Company’s website.

Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management’s beliefs and assumptions only as of the date of this press release and should not be relied upon as representing the Company’s expectations or beliefs as of any date subsequent to the time they are made. The Company does not undertake to and specifically declines any obligation to update any forward-looking statements that may be made from time to time by or on behalf of the Company.

Clearwater Analytics Holdings, Inc.

Consolidated Balance Sheets

(In thousands, except share amounts and per share amounts, unaudited)

 

March 31

December 31

2025

2024

Assets

Current assets:

Cash and cash equivalents

$

275,159

$

177,350

Short-term investments

7,695

78,139

Accounts receivable, net

111,447

106,151

Prepaid expenses and other current assets

27,762

23,006

Total current assets

422,063

384,646

Property and equipment, net

14,747

14,797

Operating lease right-of-use assets, net

23,124

24,797

Deferred contract costs, non-current

5,985

7,013

Debt issuance costs - line of credit

291

339

Deferred tax assets, net

600,626

602,500

Other non-current assets

2,990

3,340

Intangible assets, net

142,869

30,868

Goodwill

72,627

70,971

Long-term investments

30,301

Total assets

$

1,285,322

$

1,169,572

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$

2,042

$

2,934

Accrued expenses and other current liabilities

60,514

55,654

Deferred revenue

9,061

7,329

Notes payable, current portion

2,750

2,750

Operating lease liability, current portion

8,584

8,350

Tax receivable agreement liability

35

Total current liabilities

82,951

77,052

Notes payable, less current maturities and unamortized debt issuance costs

42,497

43,164

Operating lease liability, less current portion

15,719

17,655

Other long-term liabilities

1,548

1,470

Total liabilities

142,715

139,341

Stockholders' Equity

Class A common stock, par value $0.001 per share; 1,500,000,000 shares authorized, 226,434,329 shares issued and outstanding as of March 31, 2025, 212,857,580 shares issued and outstanding as of December 31, 2024

226

213

Class B common stock, par value $0.001 per share; 500,000,000 shares authorized, no share issued and outstanding as of March 31, 2025, and December 31, 2024

Class C common stock, par value $0.001 per share; 500,000,000 shares authorized, 12,542,110 shares issued and outstanding as of March 31, 2025, and December 31, 2024

13

13

Class D common stock, par value $0.001 per share; 500,000,000 shares authorized, 16,155,059 shares issued and outstanding as of March 31, 2025, 22,243,668 shares issued and outstanding as of December 31, 2024

16

22

Additional paid-in-capital

827,389

725,174

Accumulated other comprehensive income (loss)

1,978

(1,113

)

Retained earnings

286,208

283,946

Total stockholders' equity attributable to Clearwater Analytics Holdings, Inc.

1,115,830

1,008,255

Non-controlling interests

26,777

21,976

Total stockholders' equity

1,142,607

1,030,231

Total liabilities and stockholders' equity

$

1,285,322

$

1,169,572

Clearwater Analytics Holdings, Inc.

Consolidated Statements of Operations

(In thousands, except share amounts and per share amounts, unaudited)

 

Three Months Ended

March 31,

2025

2024

Revenue

$

126,864

$

102,719

Cost of revenue(1)

33,924

28,178

Gross profit

92,940

74,541

Operating expenses:

Research and development(1)

37,400

37,676

Sales and marketing(1)

19,631

16,311

General and administrative(1)

28,827

20,720

Total operating expenses

85,858

74,707

Income (loss) from operations

7,082

(166

)

Interest income, net

(1,694

)

(2,060

)

Tax receivable agreement expense

286

Other (income) expense, net

290

(530

)

Income before income taxes

8,486

2,138

Provision for (benefit from) income taxes

1,550

(98

)

Net income

6,936

2,236

Less: Net income attributable to non-controlling interests

426

338

Net income attributable to Clearwater Analytics Holdings, Inc.

$

6,510

$

1,898

Net income per share attributable to Class A and Class D common stockholders stock:

Basic

$

0.03

$

0.01

Diluted

$

0.03

$

0.01

Weighted average shares of Class A and Class D common stock outstanding:

Basic

237,324,564

213,259,463

Diluted

246,212,517

255,458,196

(1) Amounts include equity-based compensation as follows:

Cost of revenue

$

3,464

$

3,146

Operating expenses:

Research and development

8,698

8,911

Sales and marketing

4,009

3,821

General and administrative

7,541

8,347

Total equity-based compensation expense

$

23,712

$

24,225

Clearwater Analytics Holdings, Inc.

Consolidated Statements of Cash Flows

(In thousands, unaudited)

 

Three Months Ended March 31,

2025

2024

OPERATING ACTIVITIES

Net income

$

6,936

$

2,236

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

3,146

2,550

Noncash operating lease cost

2,375

2,232

Equity-based compensation

23,712

24,225

Amortization of deferred contract acquisition costs

1,350

1,217

Amortization of debt issuance costs, included in interest expense

69

69

Deferred tax benefit

1,250

(1,022

)

Accretion of discount on investments

(284

)

(574

)

Realized gain on investments

(112

)

Changes in operating assets and liabilities:

Accounts receivable, net

(5,296

)

(4,676

)

Prepaid expenses and other assets

(2,576

)

(4,198

)

Deferred contract acquisition costs

7

(747

)

Accounts payable

(918

)

9

Accrued expenses and other liabilities

(5,124

)

(9,444

)

Tax receivable agreement liability

(35

)

(1,840

)

Net cash provided by operating activities

24,500

10,037

INVESTING ACTIVITIES

Purchases of property and equipment

(1,468

)

(1,438

)

Purchase of held to maturity investments

(4,686

)

Purchases of available-for-sale investments

(31,898

)

Proceeds from sale of available-for-sale investments

89,479

Proceeds from maturities of investments

16,200

21,536

Net cash provided by (used in) investing activities

99,525

(11,800

)

FINANCING ACTIVITIES

Proceeds from exercise of options

104

Taxes paid related to net share settlement of equity awards

(24,402

)

(28,774

)

Repayments of borrowings

(688

)

(687

)

Payment of debt issuance costs

(2,159

)

Payment of acquisition holdback liability

(780

)

Payment of tax distributions

(8

)

Net cash used in financing activities

(27,249

)

(30,145

)

Effect of exchange rate changes on cash and cash equivalents

1,033

(213

)

Change in cash and cash equivalents during the period

97,809

(32,121

)

Cash and cash equivalents, beginning of period

177,350

221,765

Cash and cash equivalents, end of period

$

275,159

$

189,644

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

Cash paid for interest

$

1,282

$

911

Cash paid for income taxes

$

583

$

445

NON-CASH INVESTING AND FINANCING ACTIVITIES

Purchase of property and equipment included in accounts payable and accrued expense

$

64

$

83

Release of tax distributions payable to Continuing Equity Owners accrued in prior year

$

(23

)

$

(512

)

Tax distributions payable to Continuing Equity Owners included in accrued expenses

$

29

$

2,433

Acquisition of intangible assets paid in common stock

$

102,729

$

Acquisition holdback liability included in accrued expenses and other liabilities

$

10,000

$

3,905

Clearwater Analytics Holdings, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(In thousands, unaudited)

 

Three Months Ended March 31,

2025

2024

(in thousands, except percentages)

Net income

$

6,936

5

%

$

2,236

2

%

Adjustments:

Interest income, net

(1,694

)

(1

%)

(2,060

)

(2

%)

Depreciation and amortization

3,146

2

%

2,550

2

%

Equity-based compensation expense and related payroll taxes

27,562

22

%

28,481

28

%

Tax receivable agreement expense

%

286

0

%

Transaction expenses(1)

7,280

6

%

802

1

%

Provision for (benefit from) income tax expense

1,550

1

%

(98

)

0

%

Other expense, net

290

0

%

5

0

%

Adjusted EBITDA

45,070

36

%

32,202

31

%

Revenue

$

126,864

100

%

$

102,719

100

%

(1) Transaction expenses primarily consist of professional fees and administrative costs for closed and pending acquisitions.

Clearwater Analytics Holdings, Inc.

Reconciliation of Free Cash Flow

(In thousands, unaudited)

 

Three Months Ended March 31,

2025

2024

Net cash provided by operating activities

$

24,500

$

10,037

Less: Purchases of property and equipment

1,468

1,438

Free Cash Flow

$

23,032

$

8,599

Clearwater Analytics Holdings, Inc.

Reconciliation of Non-GAAP Information

(In thousands, except share amounts and per share amounts, unaudited)

 

Three Months Ended March 31,

2025

2024

Revenue

$

126,864

$

102,719

Gross profit

$

92,940

$

74,541

Adjustments:

Equity-based compensation expense and related payroll taxes

4,374

3,522

Depreciation and amortization

2,764

2,102

Gross profit, non-GAAP

$

100,078

$

80,165

As a percentage of revenue, non-GAAP

79

%

78

%

Cost of Revenue

$

33,924

$

28,178

Adjustments:

Equity-based compensation expense and related payroll taxes

4,374

3,522

Depreciation and amortization

2,764

2,102

Cost of revenue, non-GAAP

$

26,786

$

22,554

As a percentage of revenue, non-GAAP

21

%

22

%

Research and development

$

37,400

$

37,676

Adjustments:

Equity-based compensation expense and related payroll taxes

9,827

11,874

Depreciation and amortization

122

201

Research and development, non-GAAP

$

27,451

$

25,601

As a percentage of revenue, non-GAAP

22

%

25

%

Sales and marketing

$

19,631

$

16,311

Adjustments:

Equity-based compensation expense and related payroll taxes

5,000

4,169

Depreciation and amortization

153

135

Sales and marketing, non-GAAP

$

14,478

$

12,007

As a percentage of revenue, non-GAAP

11

%

12

%

General and administrative

$

28,827

$

20,720

Adjustments:

Equity-based compensation expense and related payroll taxes

8,361

8,916

Depreciation and amortization

107

112

Amortization of prepaid management fees and reimbursable expenses

535

Transaction expenses

7,280

802

General and administrative, non-GAAP

$

13,079

$

10,355

As a percentage of revenue, non-GAAP

10

%

10

%

Income (loss) from operations

$

7,082

$

(166

)

Adjustments:

Equity-based compensation expense and related payroll taxes

27,562

28,481

Depreciation and amortization

3,146

2,550

Amortization of prepaid management fees and reimbursable expenses

535

Transaction expenses

7,280

802

Income from operations, non-GAAP

$

45,070

$

32,202

As a percentage of revenue, non-GAAP

36

%

31

%

Net income

$

6,936

$

2,236

Adjustments:

Equity-based compensation expense and related payroll taxes

27,562

28,481

Depreciation and amortization

3,146

2,550

Tax receivable agreement expense

286

Amortization of prepaid management fees and reimbursable expenses

535

Transaction expenses

7,280

802

Tax impacts of adjustments to net income(1)

(10,069

)

(8,698

)

Net income, non-GAAP

$

34,855

$

26,192

As a percentage of revenue, non-GAAP

27

%

25

%

Net income per share - basic, non-GAAP

$

0.15

$

0.12

Net income per share - diluted, non-GAAP

$

0.13

$

0.10

Weighted-average common shares outstanding - basic

237,324,564

213,259,463

Weighted-average common shares outstanding - diluted

258,754,627

255,458,196

(1) The non-GAAP effective tax rate was 25% for the three months ended March 31, 2025 and 2024, respectively, and has been used to adjust the provision for income taxes for non-GAAP net income and non-GAAP basic and diluted net income per share.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250430092232/en/

Contacts

Investor Contact:
Joon Park | +1 415-906-9242 | investors@clearwateranalytics.com

Media Contact:
Claudia Cahill | +1 703-728-1221 | press@clearwateranalytics.com

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10